”) and Apicore US LLC’s(“Apicore”) (together, “Mylan”) motion for a preliminaryinjunction precluding Aurobindo from making, using,selling, offering to sell, and importing the accused isosulfanblue (“ISB”) product that allegedly infringes three ofApicore’s patents—U.S. [read post]